NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $254,000 | -30.4% | 3,137 | 0.0% | 0.07% | -50.7% |
| Q3 2021 | $365,000 | -29.8% | 3,137 | 0.0% | 0.14% | +6.8% |
| Q2 2021 | $520,000 | +18.7% | 3,137 | 0.0% | 0.13% | +47.8% |
| Q1 2021 | $438,000 | -98.9% | 3,137 | -98.7% | 0.09% | -98.9% |
| Q4 2020 | $41,392,000 | +104.7% | 239,122 | +64.7% | 8.25% | +67.4% |
| Q3 2020 | $20,220,000 | -12.2% | 145,153 | -24.7% | 4.93% | -9.8% |
| Q2 2020 | $23,028,000 | -17.6% | 192,754 | -19.0% | 5.46% | +10.1% |
| Q4 2019 | $27,961,000 | +29.5% | 237,883 | -5.3% | 4.96% | -12.5% |
| Q3 2019 | $21,589,000 | +106.4% | 251,127 | +55.7% | 5.67% | +160.2% |
| Q2 2019 | $10,458,000 | – | 161,321 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |